Mark Kindy, Ph.D.
BS, Zoology/Chemistry, 1980, University of Massachusetts, MA
Ph.D., Biochemistry, 1987, Boston University School of Medicine, MA
Dr. Kindy’s research is focused on the molecular basis of disease. Identification of novel targets for drug therapy, specifically, understanding the amyloid formation in Alzheimer’s disease, identifying signal transduction pathways in stroke and spinal cord injury, are among his foci. The primary goal of the laboratory is to determine the underlying mechanisms of these diseases and identify targets and compounds for treatment. Dr. Kindy has international renown for his research on the role of signaling mechanisms in ischemic injury and for the role of the RAGE receptor in amyloid diseases.